Gene-expression-based classification and regression are major concerns in translational genomics. If the feature-label distribution is known, then an optimal classifier can be derived. If the predictor-target distribution is known, then an optimal regression function can be derived. In practice, neither is known, data must be employed, and, for small samples, prior knowledge concerning the feature-label or predictor-target distribution can be used in the learning process. Optimal Bayesian classification and optimal Bayesian regression provide optimality under uncertainty. With optimal Bayesian classification (or regression), uncertainty is treated directly on the feature-label (or predictor-target) distribution. The fundamental engineering problem is prior construction. The Regularized Expected Mean Log-Likelihood Prior (REMLP) utilizes pathway information and provides viable priors for the feature-label distribution, assuming that the training data contain labels. In practice, the labels may not be observed. This paper extends the REMLP methodology to a Gaussian mixture model (GMM) when the labels are unknown. Prior construction bundled with prior update via Bayesian sampling results in Monte Carlo approximations to the optimal Bayesian regression function and optimal Bayesian classifier. Simulations demonstrate that the GMM REMLP prior yields better performance than the EM algorithm for small data sets. We apply it to phenotype classification when the prior knowledge consists of colon cancer pathways.

Download full-text PDF

Source
http://dx.doi.org/10.1109/TCBB.2017.2778715DOI Listing

Publication Analysis

Top Keywords

optimal bayesian
20
bayesian regression
12
predictor-target distribution
12
gaussian mixture
8
mixture model
8
classification regression
8
feature-label distribution
8
distribution optimal
8
regression function
8
prior knowledge
8

Similar Publications

The therapeutic failure of infliximab therapy remains a challenge in patients with inflammatory bowel disease (IBD), and dose optimization is often required. Accelerated or intensified regimes showed value in treating patients in the acute setting with high CRP or low albumin levels, which are suggested by recent guidelines; however, evidence is weak. Therapeutic drug monitoring (TDM), with anti-tumor necrosis factor-alpha (TNF-α) trough levels and antibodies, showed value during maintenance therapy, but not in induction and can guide clinical decisions in patients that might be undertreated with the standard dosing regimen.

View Article and Find Full Text PDF

Improving the Effectiveness of Sample Size Re-Estimation: An Operating Characteristic Focused, Hybrid Frequentist-Bayesian Approach.

Stat Med

February 2025

Biostatistics, Innovatio Statistics Inc., Bridgewater, New Jersey, USA.

Sample size re-estimation (SSR) is perhaps the most used adaptive procedure in both frequentist and Bayesian adaptive designs for clinical trials. The primary focus of all current frequentist and Bayesian SSR procedures is type I error control. We propose a hybrid frequentist-Bayesian SSR approach that focuses on optimizing operating characteristics (OC), which uses simulations to investigate the associated OC and adjusts accordingly.

View Article and Find Full Text PDF

QCforever is a wrapper designed to automatically and simultaneously calculate various physical quantities using quantum chemical (QC) calculation software for blackbox optimization in chemical space. We have updated it to QCforever2 to search the conformation and optimize density functional parameters for a more accurate and reliable evaluation of an input molecule. In blackbox optimization, QCforever2 can work as compactly arranged surrogate models for costly chemical experiments.

View Article and Find Full Text PDF

Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial.

Lancet Neurol

February 2025

Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada; Department of Cognitive Neurology, St Joseph's Health Care London, London, ON, Canada. Electronic address:

Background: No treatments exist for apathy in people with frontotemporal dementia. Previously, in a randomised double-blind, placebo-controlled, dose-finding study, intranasal oxytocin administration in people with frontotemporal dementia improved apathy ratings on the Neuropsychiatric Inventory over 1 week and, in a randomised, double-blind, placebo-controlled, crossover study, a single dose of 72 IU oxytocin increased blood-oxygen-level-dependent signal in limbic brain regions. We aimed to determine whether longer treatment with oxytocin improves apathy in people with frontotemporal dementia.

View Article and Find Full Text PDF

Elephant Sound Classification Using Deep Learning Optimization.

Sensors (Basel)

January 2025

School of Computer Science and Informatics, Cardiff University, Cardiff CF24 3AA, UK.

Elephant sound identification is crucial in wildlife conservation and ecological research. The identification of elephant vocalizations provides insights into the behavior, social dynamics, and emotional expressions, leading to elephant conservation. This study addresses elephant sound classification utilizing raw audio processing.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!